Altamira Therapeutics CYTOF
OTC CYTOF
$0.09 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Altamira Therapeutics Ltd. (CYTOF) Debt Ratio (2016 - 2025)

Updated

Altamira Therapeutics' (CYTOF) Debt Ratio came in at 0.06 for Q2 2025.

Analysis

Altamira Therapeutics Ltd. (CYTOF) Debt Ratio (2016 - 2025) Analysis & Trends

For FY2023, Altamira Therapeutics' Debt Ratio stood at 0.01, down 98.7% from FY2022.

  • In prior years, Altamira Therapeutics' Debt Ratio was 0.93 in FY2022, 0.00 in FY2021 (-93.6%) and 0.05 in FY2020.
  • The Q2 2025 figure stands as the highest quarterly Debt Ratio since Q2 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 0.06
Dec 31, 2023 0.01
Jun 30, 2023 0.49
Jan 1, 2023 0.93
Dec 31, 2022 0.97
Jun 30, 2022 0.25
Dec 31, 2021 0.01
Dec 31, 2020 0.03
Jun 30, 2020 0.01
Dec 31, 2018 0.15
Dec 31, 2017 0.57
Dec 31, 2016 0.35
API Access

Altamira Therapeutics Ltd. Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CYTOF&period=max&api_key=YOUR_API_KEY